Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf235 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Erik Claes und 12 weiteren Autor:innen. Beteiligte Einrichtung: ASTARC (Antwerp Surgical Training, Anatomy and Research Centre), University of Antwerp, 2610 Wilrijk, Belgium. Hauptthemen laut MEDLINE: Deoxycytidine, Lung Neoplasms, Pulmonary Artery, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Flemish Cancer Society, Collen Francqui Foundation.
Abstract (Originalsprache)
Objective
Intravenous (i.v.) chemotherapy for lung cancer is limited by systemic toxicities, reducing the maximum tolerated dose. Selective pulmonary artery perfusion (SPAP) with blood flow occlusion (BFO) is an endovascular loco-regional technique developed to increase local drug concentrations in lung tissue while minimizing systemic exposure. This study compares the pharmacokinetics of gemcitabine and its metabolites between SPAP-BFO and i.v. administration while evaluating safety.
Design
Four groups (5 pigs/group) received gemcitabine (1.25 g/m2): i.v. for 30 min, SPAP-BFO 0% (10 min SPAP without BFO), SPAP-BFO 50% (10 min SPAP with 50% BFO), and SPAP-BFO 100% (10 sec SPAP followed by 9 min 50 sec complete BFO). Concentrations of gemcitabine (2′,2′-difluoro-2′-deoxycytidine [dFdC], prodrug) and metabolites (inactive 2′,2′-difluoro-2′-deoxyuridine [dFdU], active 2’,2’-difluoro-2’-deoxycytidine triphosphate [dFdCTP]) were measured in plasma and after 30 min in lung tissue.
Results
With SPAP-BFO, no physiological effects nor acute lung damage were observed. Systemic dFdC exposure was significantly higher in the BFO 0% (vs i.v., P < 0.001; vs BFO 100%, P < 0.001) and BFO 50% (vs i.v., P < 0.01; vs BFO 100%, P < 0.01) groups. Lung tissue showed greater dFdCTP exposure with SPAP-BFO 100% over time compared to controls (P < 0.01) and BFO 0% (P < 0.05). At the end of the procedure, mean intracellular dFdCTP concentrations were significantly higher in the BFO 50% (1.43-fold, P < 0.05) and BFO 100% groups (1.95-fold, P < 0.001) compared to i.v.
Conclusions
SPAP-BFO with gemcitabine is safe and significantly increases dFdCTP lung concentrations. The SPAP-BFO 100% protocol, which enhances lung dFdCTP levels while reducing systemic exposure, shows the greatest potential and warrants further investigation as an endovascular loco-regional treatment for lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ASTARC (Antwerp Surgical Training, Anatomy and Research Centre), University of Antwerp, 2610 Wilrijk, Belgium.
- Department of Thoracic and Vascular Surgery, University Hospital Antwerp, 2650 Edegem, Belgium.
- Department of Pulmonology, University Hospital Antwerp, 2650 Edegem, Belgium.
- BioNotus CommV, 2845 Niel, Belgium.
- Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KUL, 3000 Leuven, Belgium.
- Toxicological Centre, University of Antwerp, 2610 Wilrijk, Belgium.
ORCID-Profile: Erik Claes, Celine Gys
Förderung
- Flemish Cancer Society
- Collen Francqui Foundation
Zitieren
APA
Claes, E., Verleden, S. E., De Raedemaecker, J., Annaert, P., Gys, C., Cleys, P., Lapperre, T. S., Van Schil, P. E., Covaci, A., Snoeckx, A., Peeters, D. J. E., Neyrinck, A. P., & Hendriks, J. M. H. (2025). Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf235
Vancouver
Claes E, Verleden SE, De Raedemaecker J, Annaert P, Gys C, Cleys P, et al. Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf235
BibTeX
@article{Claes2025,
author = {Claes, Erik and Verleden, Stijn E and De Raedemaecker, Joke and Annaert, Pieter and Gys, Celine and Cleys, Paulien and Lapperre, Thérèse S and Van Schil, Paul E and Covaci, Adrian and Snoeckx, Annemiek and Peeters, Dieter J E and Neyrinck, Arne P and Hendriks, Jeroen M H},
title = {Selective Pulmonary Artery Perfusion with Blood Flow Occlusion as a Treatment for Lung Malignancies},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf235}
}
EUVIMED